Search This Blog

Sunday, April 23, 2017

Pfizer Unveils ATLAS®, An Interactive, User-Friendly Website That Provides Global Antibiotic Resistance Surveillance Data Across 60 Countries | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. today announced the launch of the company’s Antimicrobial Testing Leadership and Surveillance (ATLAS) website, which is designed to provide physicians and the global health community with easy access to critical data on the efficacy of various antibiotic treatments and emerging resistance patterns across more than 60 countries. Understanding evolving bacterial resistance patterns is a key element in managing the rise of antimicrobial resistance. To that end, ATLAS can not only help physicians select the most appropriate treatment choices for their patients, but also enable global health authorities to develop data-driven antimicrobial resistance mitigation strategies. Pfizer will formally unveil ATLAS on April 22nd at the annual meeting of the European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna.



Pfizer Unveils ATLAS®, An Interactive, User-Friendly Website That Provides Global Antibiotic Resistance Surveillance Data Across 60 Countries | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company

No comments:

Post a Comment